Washington Trust’s Idexx Laboratories IDXX Stock Holding History

Washington Trust’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3	Closed	-$1.31K	–	893
2023 Q3	$1.31K	Hold	3	–	–	﹤0.01%	815
2023 Q2	$1.51K	Hold	3	–	–	﹤0.01%	818
2023 Q1	$1.5K	Sell	3 -1	-25%	-$479	﹤0.01%	841
2022 Q4	$1.63K	Hold	4	–	–	﹤0.01%	843
2022 Q3	$1K	Buy	4 +2	+100%	+$735	﹤0.01%	869
2022 Q2	$1K	Sell	2 -1	-33%	-$408	﹤0.01%	873
2022 Q1	$2K	Hold	3	–	–	﹤0.01%	830
2021 Q4	$2K	Sell	3 -15	-83%	-$9.42K	﹤0.01%	836
2021 Q3	$11K	Hold	18	–	–	﹤0.01%	770
2021 Q2	$12K	Buy	18 +14	+350%	+$7.73K	﹤0.01%	758
2021 Q1	$2K	Hold	4	–	–	﹤0.01%	906
2020 Q4	$2K	Sell	4 -1	-20%	-$447	﹤0.01%	880
2020 Q3	$2K	Hold	5	–	–	﹤0.01%	869
2020 Q2	$2K	Hold	5	–	–	﹤0.01%	771
2020 Q1	$1K	Buy	+5	New	+$1.3K	﹤0.01%	897

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Washington Trust's IDXX Position: Q4 2023 in Review

Washington Trust sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 3 shares — an estimated $1.31K sold.

Washington Trust first reported a position in IDXX in Q1 2020 and held it in 15 quarters. The position peaked at $12K in Q2 2021. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

Washington Trust reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
Washington Trust sold 3 Idexx Laboratories shares in Q4 2023, an estimated $1.31K.
Washington Trust first reported a position in Idexx Laboratories in Q1 2020 and held it in 15 quarters.
Washington Trust's Idexx Laboratories position peaked at $12K in Q2 2021.
1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Washington Trust's 13F filing for Q4 2023, filed 18 Jan 2024.